An interventional study of Internet Cognitive-Behavioral Therapy and Sham treatment in Depression - Major Depressive Disorder, sponsored by National Science and Technology Council, Taiwan. Recruiting at 1 site in Taiwan. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-30.
Sponsored by National Science and Technology Council, Taiwan · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 166 studies in Depression with a site in Taiwan — 36 open to participants now, 43 under way, 3 of them phase 3. Depression · Taiwan.
Among the 166 studies in Depression with a site in Taiwan, this one is the 50th largest by planned enrollment of the 141 interventional ones that give a count, is one of 16 that started in 2025, is one of 118 with no phase, reaches primary completion later than 21 of the 42 other live ones, and was the 148th registered.
8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.
Browse Depression studies →36 of the 166 studies in Depression with a site in Taiwan are open now. Recruiting first, the newest first:
Kaohsiung Medical University Chung-Ho Memorial Hospital · Sites in Taiwan
Ages 65+ · Healthy volunteers
National Yang Ming Chiao Tung University Hospital · Sites in Taiwan
Ages 40–90
Chang Gung Memorial Hospital · Sites in Taiwan
Ages 40+ · Healthy volunteers
Eli Lilly and Company · Sites in Taiwan, United States, Australia and 12 more countries
Ages 18–75
Chung Shan Medical University · Sites in Taiwan
Ages 18–65 · Healthy volunteers
A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →
Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.
This study: 18 Years to 75 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
166 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 7 · Phase 3 15 · Phase 4 3
First in 2004; this study’s year is marked. 16 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is above the median of 81 across 7,089 interventional studies indexed under Depression.
Median enrollment 80 across the 141 interventional studies, 239 across the 24 observational. Of the 91 that completed or were terminated, 13 (14%) have results posted.
This tab as a report to print or save as PDF → With an account.
16 of 166 have an industry lead sponsor. The 10 most frequent:
National Science and Technology Council, Taiwan is the lead sponsor of 6 studies on the registry; 3 are open to participants now.
National Science and Technology Council, Taiwan has 3 studies filed under Depression — fewer than ten, so there is no comparison to draw.
15 of the studies in Depression with a site in Taiwan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06854497Chiayi Christian HospitalThe Impact of Non-motor Symptom on the Outcome of Stroke Subjects | 2026-12-31 |
| NCT07604389Tungs' Taichung Metroharbour HospitalAR Health Education Video for Postoperative Breast Cancer Patients | 2026-12-31 |
| NCT06337773Fooyin UniversityDeveloping the Precision Nursing Education Program to Young Colorectal Cancer Survivors | 2027-01-13 |
| NCT06284551National Taiwan University HospitalThe Relationship Between Internet-use Behavior and Mental Health in Youth | 2027-01-24 |
| NCT06853106Taipei Medical UniversityDigital Sleep Program for College Students with Insomnia | 2027-02-28 |
Add all 15 to your calendar (.ics) → With an account.
Among the 166 studies in Depression with a site in Taiwan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This project aims to integrate digital phenotyping and AI-driven iCBT into a comprehensive platform for MDD diagnosis and treatment in Taiwan. The study will explore dynamic, real-time behavioral and physiological markers to refine diagnostic classifications and optimize personalized therapeutic strategies.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Behavioral: Internet Cognitive-Behavioral Therapy
Behavioral: Sham treatment
GPT-powered iCBT the participants will receive 8 sessions (30 minutes per session)
Also known as: iCBT
Sham (relaxation/supportive interaction) treatment at Day 2, 5, 9, 12, 16, 19, 23, 27.
Depression Severity
Depression severity is measured by the 21-item Hamilton Rating Scale for Depression (HAM-D). A higher score indicates greater severity, a score of ≥18 indicates moderate to severe depression.
Time frame: Weeks 0, 1, 2, 4, 8, 12, 16, 20, 24
Depression Severity
Depression severity is measured by the 9-item Patient Health Questionnaire (PHQ-9). A score of ≥10 is the most common threshold used to identify individuals likely to have major depressive disorder.
Time frame: Weeks 0, 1, 2, 4, 8,12, 16, 20, 24
Stress Level
Stress level is measured by the Life Events Perceived Stress (LEPS). A total score of ≥27 is widely recognized as the cut-off for high perceived stress.
Time frame: Weeks 0, 1, 2, 4, 8,12, 16, 20, 24
Quality of Life Assessment
Quality of Life Assessment is measured by the EuroQol questionnaire (EQ-5D). The Index Score (usually 0 to 1), where 1.0 is full health, index scores below 0.6 are often characterized as representing low quality of life
Time frame: Weeks 0, 1, 2, 4, 8, 12, 16, 20, 24
Psychological well-being
Psychological well-being is measured by the Brief Live Experience Questionnaire (BLEQ12). Score Range: 0-36; higher scores indicate greater general psychological well-being.
Time frame: Weeks 0, 4
Resilience Scale
Resilience is measured by the Resilience Scale for Adults (RSA). The scale uses a 7-point semantic differential scale (e.g., ranging from "Difficult to accomplish" to "Possible to accomplish"), with a total score range of: 33 to 231.
Time frame: Weeks 0, 4
Potential traumatic experiences
Resilience is measured by the Adverse Childhood Experiences-International Questionnaire. ACE Score (0-13): One point is given for each category of trauma experienced. The "Cut-off": A score of ≥4 is the widely recognized threshold where the risk of chronic disease, depression, and social problems increases significantly.
Time frame: Weeks 0, 4
Nutrition Assessment
Nutrition Assessment is measured by the Taiwanese version of the Mini Nutrition Assessment (MNA). The MNA Long Form consists of 18 items with a maximum score of 30 points, where a score of 24 to 30 points indicates normal nutritional status, 17 to 23.5 points indicates a risk of malnutrition, and less than 17 points signifies that the individual is malnourished.
Time frame: Weeks 0, 4
Peripheral Neuropathy Symptom Assessment
Peripheral Neuropathy Symptom is measured by the self-reported Neurotoxicity Rating Scale (NTRS)
Time frame: Weeks 0, 4
Physical Activity Level
Continuous monitoring of daily physical activity via the Garmin Vívoactive 5 wearable device. Unit of Measure: number of steps per day. \<5,000 steps/day is often defined as "sedentary," while \>7,500 steps/day is "physically active"
Time frame: Weeks 0, 1, 2, 4, 8, 12, 16, 20, 24
Heart Rate Variability (HRV)
Continuous monitoring of the variation in time between consecutive heartbeats measured during rest using the Garmin Vívoactive 5. Unit of Measure: Root mean square of successive differences (RMSSD) in milliseconds (ms). Absolute Values (RMSSD): For healthy adults (ages 38-42), a normal range is typically 19-48 ms. Scores significantly below this (e.g., \<20 ms) are often used as a cut-off for high physiological stress or poor recovery.
Time frame: Weeks 0, 1, 2, 4, 8, 12, 16, 20, 24
Sleep Patterns (Sleep Score)
Continuous monitoring is measured using the Garmin Vívoactive 5. Garmin's internal "Sleep Score" (0-100) uses 60 as the threshold for "Poor" sleep. A higher score shows better results.
Time frame: Weeks 0, 1, 2, 4, 8, 12, 16, 20, 24
Plan to share: No
No publications or documents are linked to this record.
Started Jun 2025 (actual). Primary completion is estimated for Jun 2027, 24 months after the start.
Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 24 months is above that.
Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Science and Technology Council, Taiwan